Skip to main content

Day: February 12, 2020

Ebix Hosts Q4 Investor Call Monday, March 2nd at 11:00 a.m. ET

JOHNS CREEK, Ga., Feb. 12, 2020 (GLOBE NEWSWIRE) — Ebix, Inc. (NASDAQ: EBIX), a leading international supplier of On-Demand software and E-commerce services to the insurance, financial, healthcare and e-learning industries today announced that the Company will report its 2019 fourth quarter results on Monday, March 2nd, 2020, and will host an investor conference call at 11:00 am ET on the same day to discuss the Company’s performance. The call is open to the public.About EbixWith 50+ offices across 6 continents, Ebix, Inc., (NASDAQ: EBIX) endeavors to provide On-Demand software and E-commerce services to the insurance, financial, healthcare and e-learning industries. In the Insurance sector, Ebix’s main focus is to develop and deploy a wide variety of insurance and reinsurance exchanges on an on-demand basis, while also, providing...

Continue reading

The court temporarily prohibits making changes to the Supervisory Council of JSC Olainfarm

JSC Olainfarm informs that Zemgale District Court has opened a civil lawsuit seeking to declare unlawful and invalid the decisions made at the JSC Olainfarm Extraordinary Shareholders’ meeting, which was opened on 24 January, 2020, immediately after the officially announced meeting with the purpose of making changes to the company’s existing Supervisory Council and Management Board. The court has imposed a temporary prohibition to make any changes in the composition of the existing Supervisory Council of JSC Olainfarm. The decision of the court is not subject to appeal.To recall, on 24 January, the only legitimate Extraordinary Shareholders’ meeting of JSC Olainfarm was convened at 11:00AM and did not take place due to a lack of quorum. As it has been publicly announced, immediately after the officially announced Extraordinary...

Continue reading

Tiesa uz laiku aizliedz veikt izmaiņas AS “Olainfarm” padomes sastāvā

AS “Olainfarm” informē, ka Zemgales rajona tiesā ir ierosināta civillieta, kurā lūgts atzīt par prettiesiskiem un spēkā neesošiem pieņemtos lēmumus AS “Olainfarm” ārkārtas akcionāru sapulcē, kas tika atklāta 2020. gada 24. janvārī uzreiz pēc oficiāli izsludinātās sapulces ar mērķi panākt izmaiņas uzņēmuma esošajā padomē un valdē. Tiesa kā pagaidu aizsardzības līdzekli noteikusi aizliegumu veikt izmaiņas AS “Olainfarm” esošās padomes sastāvā. Tiesas lēmums nav pārsūdzams.Jāatgādina, ka 24. janvārī AS “Olainfarm” vienīgā likumīgā ārkārtas akcionāru sapulce tika sasaukta plkst. 11.00, un tā nenotika kvoruma trūkuma dēļ. Kā publiski jau izskanējis, uzreiz pēc oficiāli izsludinātās ārkārtas akcionāru sapulces notika mēģinājums sasaukt vēl vienu sapulci ar mērķi veikt izmaiņas AS “Olainfarm” padomē un valdē. Jāuzsver, ka šī sapulce uzskatāma...

Continue reading

Interpublic Increases Common Stock Dividend for Eighth Consecutive Year

New York, Feb. 12, 2020 (GLOBE NEWSWIRE) —  Interpublic Group (NYSE: IPG) today announced that the company’s Board of Directors has declared a quarterly dividend on IPG common stock of $0.255 per share, payable on March 16, 2020, to holders of record at the close of business on March 2, 2020. The increase in the dividend from $0.235 to $0.255 per share represents a 9 percent increase to the Company’s quarterly dividend. # # #About InterpublicInterpublic is values-based, data-fueled, and creatively-driven. Major global brands include Acxiom, Craft, FCB (Foote, Cone & Belding), FutureBrand, Golin, Huge, Initiative, Jack Morton, Kinesso, MAGNA, McCann, Momentum, MRM, MullenLowe Group, Octagon, R/GA, UM and Weber Shandwick. Other leading brands include Avrett Free Ginsberg, Campbell Ewald, Carmichael Lynch, Deutsch, Hill Holliday,...

Continue reading

CURE Pharmaceutical [OTCQB:CURR] Licenses Cannabis Extraction Patents to Vanguard Scientific

LOS ANGELES, Feb. 12, 2020 (GLOBE NEWSWIRE) — CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced a licensing and collaboration agreement with Vanguard Scientific Systems, Inc., a premier provider of equipment, systems and performance solutions servicing the botanical extraction industry, including both the MIDAS XII, a next-generation GMP compliant supercritical CO2 extraction technology, as well as industrially scaled CO2 facility solutions. The license gives Vanguard the right to practice CURE’s patented cannabis extraction methods, providing customer confidence in choosing Vanguard’s portfolio of extraction manufacturers. “This license agreement gives operational freedom to a leader in the supercritical fluid extraction industry who is committed to pharma-grade standards continuing...

Continue reading

Notice to the Vaisala Corporation’s Annual General Meeting

Vaisala Corporation                                               Stock Exchange ReleaseFebruary 12, 2020 at 14.15 p.m. (EET)Notice to the Vaisala Corporation’s Annual General MeetingNotice is given to the shareholders of Vaisala Corporation of the Annual General Meeting to be held on Tuesday, April 7, 2020 at 6:00 p.m. at Vaisala Corporation’s head office, Vanha Nurmijärventie 21, 01670 Vantaa, Finland. The reception of persons who have registered for the meeting will commence at 5:00 p.m.A. MATTERS ON THE AGENDA OF THE ANNUAL GENERAL MEETING1. Opening of the Meeting2. Matters of order for the Meeting3. Election of the persons to scrutinize the minutes and to supervise the counting of votes4. Recording the legal convening of the Meeting5. Recording the attendance at the Meeting and adoption of the list of votes6. Presentation of...

Continue reading

Kutsu Vaisala Oyj:n varsinaiseen yhtiökokoukseen

Vaisala Oyj                                  Pörssitiedote                               12.2.2020 klo 14:15Kutsu Vaisala Oyj:n varsinaiseen yhtiökokoukseenVaisala Oyj:n osakkeenomistajat kutsutaan varsinaiseen yhtiökokoukseen, joka pidetään tiistaina 7.4.2020 klo 18.00 alkaen Vaisala Oyj:n pääkonttorissa, Vanha Nurmijärventie 21, 01670 Vantaa. Kokoukseen ilmoittautuneiden vastaanottaminen alkaa klo 17.00.A. VARSINAISESSA YHTIÖKOKOUKSESSA KÄSITELTÄVÄT ASIAT1. Kokouksen avaaminen2. Kokouksen järjestäytyminen3. Pöytäkirjantarkastajien ja ääntenlaskun valvojien valitseminen4. Kokouksen laillisuuden toteaminen 5. Läsnä olevien toteaminen ja ääniluettelon vahvistaminen6. Vuoden 2019 tilinpäätöksen, toimintakertomuksen ja tilintarkastuskertomuksen esittäminenToimitusjohtajan katsausTilintarkastajan katsaus7. Tilinpäätöksen vahvistaminen 8. Taseen...

Continue reading

HUS valitsi Innofactorin Terveyskylään liittyvien ICT-asiantuntijapalveluiden toimittajaksi

Innofactor Oyj:n sisäpiiritieto, julkaistu 12.2.2020 klo 14.20Helsingin ja Uudenmaan Sairaanhoitopiirin kuntayhtymä (HUS) on valinnut Innofactorin ICT-asiantuntijapalveluiden dynaamisen hankintajärjestelmän rajoitettua menettelyä käyttäen toimittamaan Terveyskylä-palveluiden arkkitehtuuri- ja sovelluskehitys, ylläpito sekä muita palveluita enintään 2 000 000 eurolla. Palvelut toimitetaan arviolta vuosien 2020-2021 aikana.Päätös on lainvoimainen hankintalain mukaisen valitusajan päätyttyä.Espoossa 12.2.2020INNOFACTOR OYJSami Ensio, toimitusjohtajaLisätietoja:Sami Ensio, toimitusjohtajaInnofactor OyjPuh. 050 584 2029sami.ensio@innofactor.comJakelu:NASDAQ HelsinkiKeskeiset mediatwww.innofactor.fiInnofactorInnofactor on johtava yritysten, julkishallinnon ja kolmannen sektorin modernin digitaalisen organisaation edistäjä Pohjoismaissa yli...

Continue reading

The Helsinki and Uusimaa Hospital District (HUS) selects Innofactor as the provider of ICT consultancy services related to Health Village

Innofactor Plc Inside Information, released on February 12, 2020, at 14:20 Finnish timeThe Helsinki and Uusimaa Hospital District (HUS) has selected Innofactor as the provider of ICT consultancy services related to Health Village. The selection was made in a bidding competition internal to the dynamic procurement. The consultancy services include architectural and system development, maintenance and other services for a maximum amount of EUR 2,000,000. The services are estimated to be provided during years 2020 and 2021.The decision will be legally valid after the appeal period defined in the Procurement Act has passed.Espoo, February 12, 2020INNOFACTOR PLCSami Ensio, CEOAdditional information:Sami Ensio, CEOInnofactor PlcTel. +358 50 584 2029sami.ensio@innofactor.comDistribution:NASDAQ HelsinkiMain mediawww.innofactor.comInnofactorInnofactor...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.